{"id":"https://openalex.org/W7204236155","doi":"https://doi.org/10.3390/vaccines14090737","title":"Estimating and Projecting Efficacy of Monoclonal Antibodies Against Respiratory Syncytial Virus Beyond Clinical Trial Periods","display_name":"Estimating and Projecting Efficacy of Monoclonal Antibodies Against Respiratory Syncytial Virus Beyond Clinical Trial Periods","publication_year":2026,"publication_date":"2026-08-26","ids":{"openalex":"https://openalex.org/W7204236155","doi":"https://doi.org/10.3390/vaccines14090737","pmid":"https://pubmed.ncbi.nlm.nih.gov/42797557"},"language":"en","primary_location":{"id":"doi:10.3390/vaccines14090737","doi":"https://doi.org/10.3390/vaccines14090737","is_oa":true,"landing_page_url":"https://doi.org/10.3390/vaccines14090737","pdf_url":null,"source":{"id":"https://openalex.org/S4210226234","display_name":"Vaccines","issn_l":"2076-393X","issn":["2076-393X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vaccines","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.3390/vaccines14090737","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100445448","display_name":"Dawei Wang","orcid":"https://orcid.org/0000-0002-7785-128X","observed_orcids":["https://orcid.org/0000-0002-7785-128X"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Dawei Wang","raw_affiliation_strings":["Health Economic and Decision Sciences, Merck & Co., Inc., Rahway, NJ 07065, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Economic and Decision Sciences, Merck & Co., Inc., Rahway, NJ 07065, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066478261","display_name":"John Lang","orcid":"https://orcid.org/0000-0002-1770-2995","observed_orcids":["https://orcid.org/0000-0002-1770-2995"]},"institutions":[{"id":"https://openalex.org/I4210095507","display_name":"Merck Canada Inc. (Canada)","ror":"https://ror.org/00rz3ed53","country_code":"CA","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210095507"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"John C. Lang","raw_affiliation_strings":["Health Economic and Decision Sciences, Merck Canada Inc., Kirkland, QC H9H 4M7, Canada"],"raw_orcid":"https://orcid.org/0000-0002-1770-2995","affiliations":[{"raw_affiliation_string":"Health Economic and Decision Sciences, Merck Canada Inc., Kirkland, QC H9H 4M7, Canada","institution_ids":["https://openalex.org/I4210095507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051779373","display_name":"Klodeta Kura","orcid":"https://orcid.org/0000-0002-0008-1440","observed_orcids":["https://orcid.org/0000-0002-0008-1440"]},"institutions":[{"id":"https://openalex.org/I4210087189","display_name":"MSD (UK) Limited (United Kingdom)","ror":"https://ror.org/004nn4n27","country_code":"GB","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210087189"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Klodeta Kura","raw_affiliation_strings":["Health Economic and Decision Sciences, MSD (UK) Limited, Moorgate, London EC2M 6UR, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Economic and Decision Sciences, MSD (UK) Limited, Moorgate, London EC2M 6UR, UK","institution_ids":["https://openalex.org/I4210087189"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5009705578","display_name":"Yao-Hsuan Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087189","display_name":"MSD (UK) Limited (United Kingdom)","ror":"https://ror.org/004nn4n27","country_code":"GB","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210087189"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Yao-Hsuan Chen","raw_affiliation_strings":["Health Economic and Decision Sciences, MSD (UK) Limited, Moorgate, London EC2M 6UR, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Economic and Decision Sciences, MSD (UK) Limited, Moorgate, London EC2M 6UR, UK","institution_ids":["https://openalex.org/I4210087189"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5100445448"],"corresponding_institution_ids":["https://openalex.org/I1285764155"],"apc_list":{"value":2700,"currency":"CHF","value_usd":3258},"apc_paid":{"value":2700,"currency":"CHF","value_usd":3258},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.69431,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"14","issue":"9","first_page":"737","last_page":"737"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11243","display_name":"Respiratory viral infections research","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11243","display_name":"Respiratory viral infections research","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/respiratory-syncytial-virus","display_name":"respiratory syncytial virus","score":1.0},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.9869999885559082},{"id":"https://openalex.org/keywords/clesrovimab","display_name":"clesrovimab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/nirsevimab","display_name":"nirsevimab","score":1.0},{"id":"https://openalex.org/keywords/force-of-infection","display_name":"force of infection","score":0.8709999918937683},{"id":"https://openalex.org/keywords/poisson-process","display_name":"Poisson process","score":0.5230000019073486},{"id":"https://openalex.org/keywords/long-term-protection","display_name":"long-term protection","score":0.44200000166893005}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6658999919891357},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5795000195503235},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.46799999475479126},{"id":"https://openalex.org/C107673813","wikidata":"https://www.wikidata.org/wiki/Q812534","display_name":"Bayesian probability","level":2,"score":0.4634999930858612},{"id":"https://openalex.org/C2780441014","wikidata":"https://www.wikidata.org/wiki/Q7907952","display_name":"Vaccine efficacy","level":3,"score":0.45730000734329224},{"id":"https://openalex.org/C2777451964","wikidata":"https://www.wikidata.org/wiki/Q2141450","display_name":"Seroconversion","level":3,"score":0.44440001249313354},{"id":"https://openalex.org/C88879693","wikidata":"https://www.wikidata.org/wiki/Q217690","display_name":"Cumulative incidence","level":3,"score":0.43860000371932983},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.4359000027179718},{"id":"https://openalex.org/C534529494","wikidata":"https://www.wikidata.org/wiki/Q7891","display_name":"Respiratory system","level":2,"score":0.42089998722076416},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.4023999869823456},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.397599995136261},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3822000026702881},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.37229999899864197},{"id":"https://openalex.org/C117251300","wikidata":"https://www.wikidata.org/wiki/Q1849855","display_name":"Parametric statistics","level":2,"score":0.3562000095844269},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.3278999924659729},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.3158999979496002},{"id":"https://openalex.org/C107130276","wikidata":"https://www.wikidata.org/wiki/Q133805","display_name":"Epidemiology","level":2,"score":0.27889999747276306},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.27880001068115234},{"id":"https://openalex.org/C100906024","wikidata":"https://www.wikidata.org/wiki/Q205692","display_name":"Poisson distribution","level":2,"score":0.27630001306533813},{"id":"https://openalex.org/C63363279","wikidata":"https://www.wikidata.org/wiki/Q5133848","display_name":"Clinical significance","level":2,"score":0.27070000767707825},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.26170000433921814},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.2612000107765198}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3390/vaccines14090737","doi":"https://doi.org/10.3390/vaccines14090737","is_oa":true,"landing_page_url":"https://doi.org/10.3390/vaccines14090737","pdf_url":null,"source":{"id":"https://openalex.org/S4210226234","display_name":"Vaccines","issn_l":"2076-393X","issn":["2076-393X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vaccines","raw_type":"journal-article"},{"id":"pmid:42797557","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42797557","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vaccines","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13611560","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13611560/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13611560/pdf/vaccines-14-00737.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Vaccines (Basel)","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:81707f9002b94938ba9b0810899c228e","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/81707f9002b94938ba9b0810899c228e","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Vaccines, Vol 14, Iss 9, p 737 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3390/vaccines14090737","doi":"https://doi.org/10.3390/vaccines14090737","is_oa":true,"landing_page_url":"https://doi.org/10.3390/vaccines14090737","pdf_url":null,"source":{"id":"https://openalex.org/S4210226234","display_name":"Vaccines","issn_l":"2076-393X","issn":["2076-393X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vaccines","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":8,"referenced_works":["https://openalex.org/W2063095964","https://openalex.org/W2203714058","https://openalex.org/W2314455166","https://openalex.org/W4313887251","https://openalex.org/W4362658059","https://openalex.org/W4389328100","https://openalex.org/W4414274541","https://openalex.org/W7165048658"],"related_works":[],"abstract_inverted_index":{"BACKGROUND:":[0],"Clinical":[1],"trials":[2],"of":[3,32,66,102,168,208,220],"respiratory":[4],"syncytial":[5],"virus":[6],"(RSV)":[7],"monoclonal":[8],"antibodies":[9],"(mAbs)":[10],"have":[11],"followed":[12],"participants":[13],"for":[14,99,109,161,184,191],"up":[15],"to":[16,26,61,204],"180":[17],"days,":[18],"covering":[19],"a":[20,56,95,105],"typical":[21],"single":[22],"RSV":[23,44,70,200],"season.":[24],"However,":[25],"assess":[27],"the":[28,64,78,100,110,176,211],"full":[29],"clinical":[30,149],"impact":[31],"mAb":[33],"administration,":[34,215],"post-trial":[35],"efficacy":[36,68,131,155],"estimates":[37,125,156],"are":[38],"needed,":[39],"particularly":[40],"in":[41],"countries":[42],"where":[43],"circulation":[45],"extends":[46],"beyond":[47,175],"six":[48],"months.":[49],"METHODS:":[50],"In":[51],"this":[52,84],"study,":[53],"we":[54,113],"applied":[55],"previously":[57],"published":[58,148],"Bayesian":[59,85],"framework":[60],"estimate":[62],"how":[63],"level":[65,207],"protective":[67],"against":[69],"provided":[71],"by":[72,126,140],"clesrovimab":[73,185],"and":[74,104,118,139,186],"nirsevimab":[75],"changes":[76],"over":[77],"first":[79,212],"year":[80,213],"after":[81],"administration.":[82],"Using":[83],"framework,":[86],"which":[87],"modeled":[88],"new":[89],"infections":[90],"as":[91],"Poisson":[92],"processes":[93],"with":[94,147,193,216],"Gaussian":[96],"process":[97],"prior":[98],"force":[101],"infection":[103],"parametric":[106],"waning":[107,120],"function":[108],"intervention":[111],"arm,":[112],"estimated":[114],"placebo":[115],"incidence":[116],"rates":[117],"posterior":[119],"functions.":[121],"We":[122],"validated":[123],"our":[124],"calculating":[127],"model-estimated":[128],"cumulative":[129,154],"trial-period":[130],"using":[132],"an":[133],"Incidence":[134],"Rate":[135],"Ratio":[136],"(IRR)":[137],"approach":[138],"reconstructing":[141],"event-free":[142],"probability":[143,167],"curves,":[144],"comparing":[145],"both":[146,162],"trial":[150,178],"results.":[151],"RESULTS:":[152],"Model-derived":[153],"closely":[157],"matched":[158],"trial-reported":[159],"results":[160],"products.":[163],"The":[164],"model-projected":[165],"instantaneous":[166],"being":[169],"protected":[170],"at":[171],"one":[172],"year-an":[173],"extrapolation":[174],"observed":[177],"follow-up-was":[179],"24.6%":[180],"(95%":[181,188],"CrI:":[182,189],"1.6-57.0%)":[183],"12.8%":[187],"1.2-44.4%)":[190],"nirsevimab,":[192],"substantially":[194],"overlapping":[195],"credible":[196],"intervals.":[197],"CONCLUSIONS:":[198],"Both":[199],"mAbs":[201],"were":[202],"projected":[203],"provide":[205],"some":[206],"protection":[209],"throughout":[210],"following":[214],"broadly":[217],"similar":[218],"levels":[219],"protection.":[221]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2026-08-27T00:00:00"}